Single-cell RNA profiling of mammary gland tumours in MMTV-PyMT mouse model of breast cancer.

Two distinct Epithelial to Mesenchymal Transition Programmes Control Invasion and Inflammation in Segregated Tumour Cell Populations

HMGN5, an RNA and Nucleosome binding protein required for chromatin de-condensation and gene activation [RNA-seq]

HMGN5, an RNA and Nucleosome binding protein required for chromatin de-condensation and gene activation [ChIP-seq]

HMGN5, an RNA and Nucleosome binding protein required for chromatin de-condensation and gene activation [CLIP-seq]

HMGN5, an RNA and Nucleosome binding protein required for chromatin de-condensation and gene activation

Single-cell RNA sequencing of adult mouse fibrotic kidney induced by unilateral uretral obstruction

Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [Hi-C]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [ChIP-seq]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [4C-seq]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [HiChIP]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [RNA-seq]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth

An epigenetic gene signature underlies phenotype switching in early stage melanomas [ChIP-seq]

Next Generation Sequencing of Primary Melanocytes, Epgn1, and Epgn3 Melanoma Cell lines [RNA-seq]

An epigenetic gene signature underlies phenotype switching in early stage melanomas [SKMel147]

An epigenetic gene signature underlies phenotype switching in early stage melanomas [YUCHIME]